Noida-based pharma Marion Biotech has come under a cloud as reports of children dying after consuming cough syrup made here came in from Uzbekistan. The matter is under investigation.
Union Health Minister Mansukh Mandaviya on Friday said that all the manufacturing activities of the Noida-based pharma company have been stopped in view of the reports of contamination in cough syrup Dok1 Max.
"Embassy of India, Tashkent has been closely following the developments related to the unfortunate death of 18 children in Uzbekistan due to alleged contamination of the cough syrup Dok1 Max manufactured by an Indian company, Marion Biotech, NOIDA, Uttar Pradesh," the Indian mission said in
This comes as India is in contact with the national drug regulator of Uzbekistan regarding reports of Noida-based cough syrups allegedly linked to the deaths of 18 children in Uzbekistan. The health ministry said that there have been reports from Uzbekistan concerning contaminated cough s
India is in regular contact with the national drug regulator of Uzbekistan regarding reports of Noida-based cough syrups allegedly linked to the deaths of 18 children in Uzbekistan, said the Union Minister of Health and Family Welfare on Thursday.
"We regret the deaths of children in Uzbekistan. The Central government is conducting an inquiry and we will take an action as per their report. They have taken samples of the medicine," legal representative of Marion Biotech Pharma Company, Hasan Harris said. The deaths of Uzbekistan chi
The statement shared with stock exchanges by the information technology firm said that Equippp shall offer the software products and services for GMR Varalakshmi Foundation for one year on mutually agreed terms.
PCV15 vaccine was developed by Tergene Biotech and manufactured at Auro Vaccines, which is a wholly-owned subsidiary of Aurobindo Pharma with capabilities in vaccines development and manufacturing. Aurobindo Pharma holds 80 per cent stake in the joint venture company, Tergene Biotech.
Mumbai (Maharashtra) [India], December 26 (ANI/NewsVoir): Fermenta Biotech Limited ('Fermenta') has commissioned a new facility to manufacture Fortified Rice Kernel ('FRK') located in Pennepalli, Tirupati district in Andhra Pradesh. With this milestone, Fermenta has entered the rice fortific
Bharat Biotech's nasal vaccine - iNCOVACC has been approved by the Government of India and will be used as a heterologous booster dose for those above 18 years of age
Singapore, December 21 (ANI/PRNewswire): For the third consecutive year, Medidata, a Dassault Systemes company, was awarded the International Innovation Award.